advertisement
Li S 62
Showing records 1 to 25 | Display all abstracts from Li S117348 Advancing Glaucoma Care: Integrating Artificial Intelligence in Diagnosis, Management, and Progression Detection
Zhu Y
Bioengineering (Basel, Switzerland) 2024; 11:
117099 Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial
Feng H
Translational vision science & technology 2024; 13: 21
117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Li S
eLife 2024; 12:
118734 Encapsulated cell technology: Delivering cytokines to treat posterior ocular diseases
Wang J
Pharmacological Research 2024; 203: 107159
118820 The significance of precisely regulating heme oxygenase-1 expression: Another avenue for treating age-related ocular disease?
Wei D
Ageing research reviews 2024; 97: 102308
117744 Ferroptosis in Glaucoma: A Promising Avenue for Therapy
Zhu J
Advanced biology 2024; 8: e2300530
117139 Characteristics of beta parapapillary atrophy in primary angle-closure suspect
Xiang F
BMJ open ophthalmology 2024; 9:
117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Ren J
eLife 2024; 12:
117348 Advancing Glaucoma Care: Integrating Artificial Intelligence in Diagnosis, Management, and Progression Detection
Salowe R
Bioengineering (Basel, Switzerland) 2024; 11:
117744 Ferroptosis in Glaucoma: A Promising Avenue for Therapy
Chen H
Advanced biology 2024; 8: e2300530
118820 The significance of precisely regulating heme oxygenase-1 expression: Another avenue for treating age-related ocular disease?
Qu C
Ageing research reviews 2024; 97: 102308
118734 Encapsulated cell technology: Delivering cytokines to treat posterior ocular diseases
Fan W
Pharmacological Research 2024; 203: 107159
117099 Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial
Han D
Translational vision science & technology 2024; 13: 21
117139 Characteristics of beta parapapillary atrophy in primary angle-closure suspect
Zhang Y
BMJ open ophthalmology 2024; 9:
117744 Ferroptosis in Glaucoma: A Promising Avenue for Therapy
Wu J
Advanced biology 2024; 8: e2300530
117139 Characteristics of beta parapapillary atrophy in primary angle-closure suspect
Zhang Q
BMJ open ophthalmology 2024; 9:
118820 The significance of precisely regulating heme oxygenase-1 expression: Another avenue for treating age-related ocular disease?
Zhao N
Ageing research reviews 2024; 97: 102308
117348 Advancing Glaucoma Care: Integrating Artificial Intelligence in Diagnosis, Management, and Progression Detection
Chow C
Bioengineering (Basel, Switzerland) 2024; 11:
117081 Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression
Jiang Z
eLife 2024; 12:
117099 Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial
Lu W
Translational vision science & technology 2024; 13: 21
118734 Encapsulated cell technology: Delivering cytokines to treat posterior ocular diseases
Liu B
Pharmacological Research 2024; 203: 107159
117744 Ferroptosis in Glaucoma: A Promising Avenue for Therapy
Li S
Advanced biology 2024; 8: e2300530
117139 Characteristics of beta parapapillary atrophy in primary angle-closure suspect
Pan X
BMJ open ophthalmology 2024; 9:
118734 Encapsulated cell technology: Delivering cytokines to treat posterior ocular diseases
Pu N
Pharmacological Research 2024; 203: 107159
118820 The significance of precisely regulating heme oxygenase-1 expression: Another avenue for treating age-related ocular disease?
Li S
Ageing research reviews 2024; 97: 102308
